Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women

OBJECTIVE: Plasma cancer antigen (CA)-125 is a tumour marker recently shown to be associated with systolic heart failure and new-onset atrial fibrillation (AF) after myocardial infarction. However, no reports have described the relationship between CA-125 and new-onset AF in healthy postmenopausal w...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekiguchi, Haruki, Shimamoto, Ken, Takano, Mayu, Kimura, Makiko, Takahashi, Yufuko, Tatsumi, Fujio, Watanabe, Eri, Jujo, Kentaro, Ishizuka, Naoko, Kawana, Masatoshi, Hagiwara, Nobuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Heart 2017
Materias:
Arrhythmias and Sudden Death
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561355/
https://www.ncbi.nlm.nih.gov/pubmed/28285269
http://dx.doi.org/10.1136/heartjnl-2016-310272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561355/
https://www.ncbi.nlm.nih.gov/pubmed/28285269
http://dx.doi.org/10.1136/heartjnl-2016-310272

Ejemplares similares